The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Zhou, Qi ^a   Wang, Yafeng ^a   Peng, Baogang ^a   Liang, Lijian ^a   Li, Jiaping ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Intrahepatic cholangiocarcinoma; Migration; Notch1

Indexed keywords

NOTCH1 RECEPTOR; RAC1 PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; BILE DUCT TUMOR; BIOSYNTHESIS; CELL MOTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; INTRAHEPATIC BILE DUCT; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CHOLANGIOCARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; UP-REGULATION;

EID: 84877843218     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-244     Document Type: Article

References (31)

1. Han JK, Lee JM. Intrahepatic intraductal cholangiocarcinoma. Abdom Imaging 2004, 29:558-564.
2. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 2004, 40:472-477. 10.1016/j.jhep.2003.11.030, 15123362.
3. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology-Basel 2004, 66:167-179.
4. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009, 28:15-33. 10.1007/s10555-008-9169-0, 19169796.
5. Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol 2012, 23:450-457. 10.1016/j.semcdb.2012.01.010, 3638987, 22306179.
6. South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol 2012, 23:458-464. 10.1016/j.semcdb.2012.01.017, 3360804, 22309843.
7. Dotto GP. Notch tumor suppressor function. Oncogene 2008, 27:5115-5123. 10.1038/onc.2008.225, 2747622, 18758480.
8. Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008, 27:5132-5137. 10.1038/onc.2008.227, 18758482.
9. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 2006, 106:2503-2513. 10.1002/cncr.21904, 16628653.
10. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer 2006, 118:1930-1936. 10.1002/ijc.21589, 16284950.
11. Shi TP, Xu H, Wei JF, Ai X, Ma X, Wang BJ, Ju ZH, Zhang GX, Wang C, Wu ZQ, Zhang X. Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival. J Urol 2008, 180:361-366. 10.1016/j.juro.2008.02.037, 18499162.
12. Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE, Andrulis IL. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat 2008, 111:439-448. 10.1007/s10549-007-9805-3, 17990101.
13. Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, Gao XD, Chen B, Li JM, Xiong SM, Gu LJ, Tang JY, Liang H, Jiang H, Xue YQ, Shen ZX, Chen Z, Chen SJ. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 2006, 12:3043-3049. 10.1158/1078-0432.CCR-05-2832, 16707600.
14. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Inhibition of T cell activation by normal human biliary epithelial cells. J Hepatol 1999, 31:1026-1033. 10.1016/S0168-8278(99)80315-8, 10604576.
15. Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 2007, 67:7203-7211. 10.1158/0008-5472.CAN-07-0473, 2867339, 17671188.
16. Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 2010, 102:351-360. 10.1038/sj.bjc.6605486, 2816657, 20010940.
17. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000, 5:197-206. 10.1016/S1097-2765(00)80416-5, 10882062.
18. Weinmaster G. The ins and outs of notch signaling. Mol Cell Neurosci 1997, 9:91-102. 10.1006/mcne.1997.0612, 9245493.
19. Dunwoodie SL, Henrique D, Harrison SM, Beddington RS. Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development 1997, 124:3065-3076.
20. Rao PK, Dorsch M, Chickering T, Zheng G, Jiang C, Goodearl A, Kadesch T, McCarthy S. Isolation and characterization of the notch ligand delta4. Exp Cell Res 2000, 260:379-386. 10.1006/excr.2000.5034, 11035934.
21. Yoneya T, Tahara T, Nagao K, Yamada Y, Yamamoto T, Osawa M, Miyatani S, Nishikawa M. Molecular cloning of delta-4, a new mouse and human Notch ligand. J Biochem 2001, 129:27-34. 10.1093/oxfordjournals.jbchem.a002832, 11134954.
22. Shutter JR, Scully S, Fan W, Richards WG, Kitajewski J, Deblandre GA, Kintner CR, Stark KL. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 2000, 14:1313-1318. 316657, 10837024.
23. Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011, 11:338-351. 10.1038/nrc3035, 21508972.
24. Koch U, Radtke F. Notch and cancer: a double-edged sword. Cell Mol Life Sci 2007, 64:2746-2762. 10.1007/s00018-007-7164-1, 17687513.
25. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009, 33:1247-1254. 10.1007/s00268-009-9970-0, 19294467.
26. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428. 10.1172/JCI39104, 2689101, 19487818.
27. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009, 119:1417-1419. 10.1172/JCI39675, 2689122, 19487817.
28. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.
29. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635. 10.1038/nature01148, 12478284.
30. Lee TK, Poon RT, Yuen AP, Man K, Yang ZF, Guan XY, Fan ST. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression. Clin Cancer Res 2006, 12:5082-5089. 10.1158/1078-0432.CCR-05-2794, 16951224.
31. Jung HB, Sohn JH, Ji EK, Song H, Mook-Jung I. Rac1 changes the substrate specificity of γ-secretase between amyloid precursor protein and Notch1. Biochem Biophys Res Commun 2008, 37:913-917.